|
|
Natera: A global leader in cell-free DNA testing
Natera advances molecular diagnostics with integrity and scientific rigor, and supports integration of information provided by our tests into health care decision making.
Natera - Wikipedia
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health.
Natera Technology Featured in 300+ Peer-Reviewed Publications ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing and precision medicine, today announced the publication of more than 300 peer-reviewed ...
Lobbying Update: $150,000 of NATERA INC lobbying was just disclosed
$150,000 of NATERA INC lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Advocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients.
About Us | Natera
We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. We validate our tests with clinical studies and make data publicly available.
Callan Family Office LLC Buys New Stake in Natera, Inc. $NTRA
Callan Family Office LLC purchased a new stake in Natera, Inc. (NASDAQ:NTRA - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 3,609 shares of the medical research company's stock, valued at approximately $610,000. Other ...
Natera, Inc. (NTRA) Company Profile & Facts - Yahoo Finance
See the company profile for Natera, Inc. (NTRA) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their...
Natera Hosts Oct 23 Investor Call on Phase 3 IMvigor011 | NTRA Stock News
Natera will host a webcast on Oct. 23 at 5:00 a.m. PT (8:00 a.m. ET) to discuss IMvigor011 and Checkmate 274 data from ESMO; Prof. Thomas Powles to join. Conference ID 7684785; replay at investor.natera.com.
Natera, Inc. (NTRA): history, ownership, mission, how it works & makes ...
Learn about Natera, Inc.s ownership, mission, and business model in this detailed overview. Discover how it generates revenue and impacts health.
Natera, Inc.: Natera to Host Investor Call on October 23, 2025 to ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will host a conference call and webcast on Thursday, Oct. 23, at 5:00 a.m. PT (8:00 a.m.
|
FIRE101 Fire Jobs 